Literature DB >> 23219600

Peripheral site and acyl pocket define selective inhibition of mouse butyrylcholinesterase by two biscarbamates.

Anita Bosak1, Ivana Gazić Smilović, Adela Stimac, Vladimir Vinković, Goran Sinko, Zrinka Kovarik.   

Abstract

In this study we related metacarb (N-(2-(3,5-bis(dimethylcarbamoyloxy)phenyl)-2-hydroxyethyl)propan-2-aminium chloride) and isocarb (N-(2-(3,4-bis(dimethylcarbamoyloxy)phenyl)-2-hydroxyethyl)propan-2-aminium chloride) inhibition selectivity, as well as stereoselectivity of mouse acetylcholinesterase (AChE; 3.1.1.7) and butyrylcholinesterase (BChE; 3.1.1.8) to the active site residues by studying the progressive inhibition of AChE, BChE and six AChE mutants with racemic and (R)-enantiomers of metacarb and isocarb. Metacarb and isocarb proved to be very potent BChE inhibitors with inhibition rate constants in the range of 10(3)-10(4)M(-1)s(-1). For metacarb and isocarb, inhibition of BChE w.t. was 260 and 35 times, respectively, faster than inhibition of AChE w.t. For four mutants inhibition was faster than for AChE w.t. but none reached the inhibition rate of BChE. The highest increase in the inhibition rate (about 30 times for metacarb and 13 times for isocarb) was achieved with mutants F295L/Y337A and Y124Q meaning that selective inhibition of mouse BChE is dictated mainly by two amino acids from BChE: leucine 286 from the acyl pocket and glutamine 119 from the peripheral site. Wild type enzymes displayed pronounced stereoselectivity for (R)-enantiomers of metacarb and isocarb. Interestingly, the residues that define selective inhibition of mouse BChE by biscarbamates also affect the stereoselectivity of enzymes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219600     DOI: 10.1016/j.abb.2012.11.012

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.

Authors:  Anita Bosak; Alma Ramić; Tamara Šmidlehner; Tomica Hrenar; Ines Primožič; Zrinka Kovarik
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

2.  Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity.

Authors:  Anita Bosak; Anamarija Knežević; Ivana Gazić Smilović; Goran Šinko; Zrinka Kovarik
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  Arylaminopropanone Derivatives as Potential Cholinesterase Inhibitors: Synthesis, Docking Study and Biological Evaluation.

Authors:  Anna Hudcová; Aleš Kroutil; Renata Kubínová; Adriana D Garro; Lucas J Gutierrez; Daniel Enriz; Michal Oravec; Jozef Csöllei
Journal:  Molecules       Date:  2020-04-10       Impact factor: 4.411

4.  Quinuclidine-Based Carbamates as Potential CNS Active Compounds.

Authors:  Ana Matošević; Andreja Radman Kastelic; Ana Mikelić; Antonio Zandona; Maja Katalinić; Ines Primožič; Anita Bosak; Tomica Hrenar
Journal:  Pharmaceutics       Date:  2021-03-20       Impact factor: 6.321

5.  Assessment of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase.

Authors:  Tena Čadež; Dora Kolić; Goran Šinko; Zrinka Kovarik
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.